Jefferies Maintains 'Hold' Rating on monday.com Ltd. Amid Director Stock Sale
2 reports, 2 independent
Updated Nov 12
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies Financial Group maintained a 'hold' rating on monday.com Ltd. on October 22, 2026. Separately, Director Aviad Eyal sold 2,000 shares of monday.com Ltd. stock on October 20th for a total value of $200,080.00, executing the trade under a Rule 10b5-1 plan. At the time of the sale, the company's stock was trading at $106.86.
From tickerreport.com
Why it matters
The rating maintained by Jefferies Financial Group influences market valuation for monday.com Ltd. The director's sale represents a 0.97% decrease in their ownership of the stock, which is disclosed in filings with the SEC.
From tickerreport.com
Who's involved
- Jefferies Financial GroupProvided the 'hold' rating on monday.com Ltd.
How it developed
Newest first. Tap a step to see who reported it.Citigroup reduced its price objective on monday.com shares, and MarketBeat provided consensus data.1 source
Jefferies maintained a 'hold' rating on monday.com.1 source
Keep exploring
The entities involved
-
Jefferies Financial Group
American financial services company
Nothing else this week.
Related events
- Jefferies Financial Group reissued a 'hold' rating on HarbourVest Global Private Equity shares.
- Jefferies Financial Group lowered its stock rating for Siemens from buy to hold.
- Analyst upgraded Ironwood Pharmaceuticals to 'hold' rating, concurrent with insider selling disclosures filed with the SEC.
- Jefferies Financial Group reiterated a buy rating on Constellation Software stock.
- Jefferies, Citigroup, and Leerink Partners issued rating updates and price targets for Phathom Pharmaceuticals.